Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Community Based Intervention01:30

Community Based Intervention

95
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
95
Birth Control Methods01:22

Birth Control Methods

2.7K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
2.7K
Factors Affecting Drug Distribution: Physiological Barriers01:23

Factors Affecting Drug Distribution: Physiological Barriers

336
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
336
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

252
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
252

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perceived Importance of Abortion Care Features and Access to Telehealth Technologies Among Medication Abortion Patients by Abortion Care Model: Cross-Sectional Analysis of a Prospective Cohort Study.

Journal of medical Internet research·2026
Same author

Importance of abortion training to residency program applicants: A national survey of OBGYN residents.

Contraception·2026
Same author

Pregnancy care-seeking stress in the USA: a prospective cohort study.

BMJ open·2026
Same author

Increasing Contraceptive Access at Sites Serving Cross-State Abortion Patients: Results From the Southwest Contraceptive Access Network (SCAN) Intervention.

American journal of public health·2026
Same author

State-Level Abortion Bans and the OBGYN Workforce: A Review of Current Evidence.

JAMA health forum·2026
Same author

Toward a Crisis Pregnancy Center Client Typology: Abortion-Seekers' Expectations and Experiences Following Implementation of Texas' Early Abortion Ban.

Perspectives on sexual and reproductive health·2026

Related Experiment Video

Updated: Sep 15, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.0K

No-Test Screening Protocols May Disproportionately Exclude Structurally Oppressed Communities Who Could Benefit from

M Antonia Biggs1, Lauren Ralph1, Katherine Ehrenreich1

  • 1Advancing New Standards in Reproductive Health (ANSIRH), Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, School of Medicine, University of California San Francisco, Oakland, California, USA.

Health Equity
|July 18, 2025
PubMed
Summary

No-test medication abortion screening excludes many eligible individuals, particularly younger people and those facing food or housing insecurity. Improved criteria are needed for equitable access to this reproductive healthcare option.

Keywords:
abortionhealth screeningno-testpregnancy

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.7K
Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

9.8K

Related Experiment Videos

Last Updated: Sep 15, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.0K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.7K
Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

9.8K

Area of Science:

  • Reproductive Health
  • Medical Screening
  • Health Equity

Background:

  • Medication abortion offers a safe and effective option for pregnancy termination.
  • No-test screening protocols aim to increase access by removing the need for certain clinical assessments.
  • Disparities in healthcare access highlight the need to evaluate screening methods for potential biases.

Purpose of the Study:

  • To compare ineligibility rates for medication abortion using no-test screening versus standard testing with ultrasound.
  • To identify demographic and socioeconomic factors associated with ineligibility under no-test criteria.
  • To assess the rate of false positives in no-test medication abortion screening.

Main Methods:

  • Prospective survey and clinical assessment of patients seeking abortion across nine facilities in eight U.S. states (June 2021-December 2022).
  • Eligibility for medication abortion assessed using both standard clinical guidelines with testing and a no-test protocol.
  • Statistical analysis to determine ineligibility proportions, false positive rates, and associations with participant characteristics.

Main Results:

  • A significantly higher proportion of patients were ineligible using no-test criteria (71.5%) compared to standard testing (21.1%).
  • No-test criteria disproportionately excluded younger individuals (15-19 years) and those experiencing food or housing insecurity.
  • Moderate/severe pelvic pain was the most common reason for ineligibility, particularly among younger, nulliparous individuals, and those with food or housing insecurity.

Conclusions:

  • Current no-test medication abortion screening criteria may create significant barriers to care, excluding eligible individuals.
  • Disparities in exclusion rates suggest that no-test protocols may exacerbate existing inequities in reproductive healthcare access.
  • Further research is essential to refine no-test screening criteria for improved equity and accessibility in medication abortion services.